Article Information
History
- September 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Arantxa Urchueguía-Fornes*,1,2,†,
- Richard Osei-Yeboah*,3,†,
- Ombeline Jollivet4,
- Caroline Klint Johannesen5,6,
- Toni Lehtonen7,
- Michiel van Boven8,9,
- David Gideonse8,
- Rachel A. Cohen10,
- Alejandro Orrico-Sánchez1,2,11,
- Rolf Kramer4,
- Thea K. Fischer6,
- Terho Heikkinen12,
- Harish Nair3,
- Harry Campbell3,
- PROMISE investigators
- ↵†Corresponding author
Richard Osei-Yeboah, PhD, Centre for Global Health, Usher Institute, The University of Edinburgh, 5-7 Little France Drive, BioQuarter Gate 3 - Edinburgh, EH16 4UX, United Kingdom., Email: Richard.Osei-Yeboah{at}ed.ac.uk, Alternate Corresponding author
, Arantxa Urchueguía-Fornes, PhD, Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain, Email: arantxa.urchueguia{at}fisabio.es
- 1Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain
- 2CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III
- 3Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom
- 4Sanofi, Lyon, France
- 5Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
- 6Department of Clinical Research, North Zealand University Hospital, Capital Region, Denmark
- 7Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
- 8Centre for Infectious Disease Control, National Institute for Public Health and the Environment, the Netherlands
- 9Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 10GSK, Rockville, Maryland, United States
- 11Catholic University of Valencia, Valencia, Spain
- 12Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland
- 13(University of Edinburgh)
- 14(THL)
- 15(RIVM)
- 16(University Medical Center Utrecht)
- 17(Imperial College London)
- 18(University of Oxford)
- 19(Novavax)
- 20(Pfizer)
- 21(GlaxoSmithKline)
- 22(Janssen)
- 23(FISABIO-Public Health)
- 24(Sanofi Pasteur)
- 25(Teamit)
Posted September 24, 2024.
RSV healthcare burden in adults before and since the emergence of the COVID-19 pandemic in 6 European countries
